Results for Advate (15)

  News   FDA Approves Baxter`s ADVATE as the Only FVIII for Routine Prophylaxis in Both Adults and Children with Hemophilia A
Baxter International Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ADVATE [Antihemophilic Factor (Recombinant) Plasma/Albumin Free Method] for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A.
  News   Biogen Idec and Swedish Orphan Biovitrum Present Data on Long-Lasting Recombinant Factor VIII Therapy at International Society on Thrombosis and Haemostasis Meeting
Biogen Idec and Swedish Orphan Biovitrum announced Phase 1/2a trial data showing that the companies` long-lasting fully-recombinant factor VIII Fc fusion protein (rFVIIIFc) was well tolerated and demonstrated an approximately 1.7-fold increase in half-life compared with Advate
  Leaflet Drug   Xyntha
Description: Antihemophilic factor (AHF) is a protein produced naturally in the body.
  Leaflet Drug   Refacto
Description: Antihemophilic factor (AHF) is a protein produced naturally in the body.
  Leaflet Drug   Recombinate
Description: Antihemophilic factor (AHF) is a protein produced naturally in the body.
  Leaflet Drug   Monoclate-P
Description: Antihemophilic factor (AHF) is a protein produced naturally in the body.
  Leaflet Drug   Monarc-M
Description: Antihemophilic factor (AHF) is a protein produced naturally in the body.
  Leaflet Drug   Kogenate FS w/BIO-SET
Description: Antihemophilic factor (AHF) is a protein produced naturally in the body.
  Leaflet Drug   Kogenate FS
Description: Antihemophilic factor (AHF) is a protein produced naturally in the body.
  Leaflet Drug   Koate DVI
Description: Antihemophilic factor (AHF) is a protein produced naturally in the body.
  Leaflet Drug   Hyate:C
Description: Antihemophilic factor (AHF) is a protein produced naturally in the body.
  Leaflet Drug   Hemofil-M
Description: Antihemophilic factor (AHF) is a protein produced naturally in the body.
  Leaflet Drug   Helixate FS
Description: Antihemophilic factor (AHF) is a protein produced naturally in the body.
  Leaflet Drug   Antihemophilic Factor (Intravenous Route, Injection Route)
Description: Antihemophilic factor (AHF) is a protein produced naturally in the body.
  Leaflet Drug   Advate
Description: Antihemophilic factor (AHF) is a protein produced naturally in the body.

General Search


 Latest News

U.S. Food And Drug Administration Approves Pfizer’s INLYTA (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)
Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph Chronic Myeloid Leukemia
FDA approves Inlyta to treat patients with a type of advanced kidney cancer
FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
FDA. New and Generic Drug Approvals - January 27, 2012

 Latest Drugs

Efavirenz Teva
Desloratadine Actavis
Repaglinide Accord
Emselex
Hepsera
Zulvac 1 Ovis
Zulvac 1 Bovis
Levetiracetam Sun
Inovelon
Olanzapine Glenmark Europe

 Latest Articles

Wrist Injuries and Disorders
Valley Fever
Verruca ( Warts)
Von Hippel-Lindau Disease
Vitiligo

Last medical tags:


Torisel, temsirolimus, Inlyta, chronic myeloid leukemia, bosutinib, Inlyta, renal cell carcinoma, kidney cancer, myelin, Tysabri, natalizumab, brain infection, progressive multifocal leukoencephalopathy, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, thoracic aortic transection, endovascular graft, methotrexate, Voraxaze, cancer chemotherapy drug, glucarpidase, Adcetris, bleomycin, multifocal leukoencephalopathy, CardioGen-82, radiation, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, raltegravir, Isentress, antiretroviral medicines, Theravance, Relovair, asthma, fluticasone, bronchitis, neuromuscular disease, SMA, muscle atrophy, Resolor, prokinetic, prucalopride, ADHD, psychiatric behavioural disorder, Venvanse, lisdexamfetamine dimesylate, type 2 diabetes mellitus, Actoplus Met XR, pioglitazone, Mylan, Eprosartan Mesylate Tablets, Teveten, antimicrobials, cephapirin, cephalosporin, teriflunomide, Rebif, alanine aminotransferase levels, flu-like symptoms, multiple sclerosis, electrical pulses, implantable pulse generator, Precision Plus Spinal Cord Stimulator, genetic blood clotting disorder, hemophilia A, Advate, bleeding episodes, heart failure, heart transplantation, Pediatric Medical Device Safety, pulsatile cardiac assist device, selective serotonin reuptake inhibitor, SSRI, pulmonary hypertension,
» All tags  
Sitemap